blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2900687

EP2900687 - RECOMBINANT MEASLES VIRUS EXPRESSING CHIKUNGUNYA VIRUS POLYPEPTIDES AND THEIR APPLICATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.03.2019
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  30.03.2018
FormerGrant of patent is intended
Status updated on  16.11.2017
FormerExamination is in progress
Status updated on  24.03.2017
FormerRequest for examination was made
Status updated on  20.03.2017
FormerExamination is in progress
Status updated on  24.02.2017
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
INSTITUT PASTEUR
25-28, rue du Docteur Roux
75724 Paris Cedex 15 / FR
For all designated states
Themis Bioscience GmbH
Muthgasse 11/2
1190 Vienna / AT
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3 rue Michel-Ange
75794 Paris Cedex 16 / FR
[2018/18]
Former [2015/32]For all designated states
INSTITUT PASTEUR
25-28, rue du Docteur Roux
75724 Paris Cedex 15 / FR
For all designated states
Themis Bioscience GmbH
Muthgasse 11/2
1190 Vienna / AT
For all designated states
Centre National de la Recherche Scientifique (CNRS)
3, rue Michel-Ange
75794 Paris Cedex 16 / FR
Inventor(s)01 / TANGY, Frédéric
60, rue du Garde Chasse
93260 Les Lilas / FR
02 / BRANDLER, Samantha
3/23 Shoobra Road
Elsternwick, Vic 3185 / AU
03 / DESPRES, Philippe
37 chemin de la Météo
97417 Saint-Denis (La Montagne) La Réunion / FR
04 / HABEL, André
Kroosweg 23
21073 Hamburg / DE
 [2018/17]
Former [2015/32]01 / TANGY, Frédéric
60, rue du Garde Chasse
93260 Les Lilas / FR
02 / BRANDLER, Samantha
c/o Mme. Veronique Grolleau 17
avenue du 11 November
F-44340 Bouguenais / FR
03 / DESPRES, Philippe
37 chemin de la Météo
97417 Saint-Denis (La Montagne) La Réunion / FR
04 / HABEL, André
Kroosweg 23
21073 Hamburg / DE
Representative(s)Desaix, Anne, et al
Ernest Gutmann - Yves Plasseraud SAS
3, rue Auber
75009 Paris / FR
[2015/32]
Application number, filing date13771106.526.09.2013
[2018/18]
WO2013EP70137
Priority number, dateEP2012030617627.09.2012         Original published format: EP 12306176
[2015/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014049094
Date:03.04.2014
Language:EN
[2014/14]
Type: A1 Application with search report 
No.:EP2900687
Date:05.08.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 03.04.2014 takes the place of the publication of the European patent application.
[2015/32]
Type: B1 Patent specification 
No.:EP2900687
Date:02.05.2018
Language:EN
[2018/18]
Search report(s)International search report - published on:EP03.04.2014
ClassificationIPC:C07K14/18, A61K39/00, A61K39/12, A61K39/295, C12N7/04, C12N15/86
[2015/32]
CPC:
A61K39/12 (EP,US); A61P31/14 (EP); C07K14/005 (EP,US);
C12N15/86 (US); C12N7/00 (US); A61K2039/5254 (EP,US);
A61K2039/5256 (EP,US); A61K2039/5258 (EP,US); A61K2039/70 (EP,US);
A61K38/00 (EP,US); C12N2760/18421 (US); C12N2760/18434 (EP,US);
C12N2760/18443 (EP,US); C12N2760/18444 (EP,US); C12N2770/36122 (US);
C12N2770/36123 (EP,US); C12N2770/36134 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/32]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:REKOMBINANTES MASERNVIRUS ZUR EXPRESSION VON CHIKUNGUNYA-VIRUS-POLYPEPTIDEN UND DEREN ANWENDUNGEN[2017/45]
English:RECOMBINANT MEASLES VIRUS EXPRESSING CHIKUNGUNYA VIRUS POLYPEPTIDES AND THEIR APPLICATIONS[2015/32]
French:VIRUS DE LA ROUGEOLE RECOMBINÉS EXPRIMANT DES POLYPEPTIDES DU VIRUS DU CHIKUNGUNYA ET LEURS APPLICATIONS[2017/45]
Former [2015/32]CHIKUNGUNYA-VIRUS-POLYPEPTIDE ZUR EXPRESSION EINES REKOMBINANTEN MASERNVIRUS UND ANWENDUNGEN DAVON
Former [2015/32]VIRUS DE LA ROUGEOLE RECOMBINANT EXPRIMANT DES POLYPEPTIDES DU VIRUS CHIKUNGUNYA ET SES APPLICATIONS
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase26.03.2015National basic fee paid 
26.03.2015Designation fee(s) paid 
26.03.2015Examination fee paid 
Examination procedure26.03.2015Examination requested  [2015/32]
17.11.2015Amendment by applicant (claims and/or description)
24.03.2017Despatch of a communication from the examining division (Time limit: M04)
27.07.2017Reply to a communication from the examining division
17.11.2017Communication of intention to grant the patent
20.03.2018Fee for grant paid
20.03.2018Fee for publishing/printing paid
20.03.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.03.2017
Opposition(s)05.02.2019No opposition filed within time limit [2019/15]
Fees paidRenewal fee
26.08.2015Renewal fee patent year 03
25.08.2016Renewal fee patent year 04
30.08.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.09.2013
AL02.05.2018
CY02.05.2018
CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
MK02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
BG02.08.2018
IS02.09.2018
MT26.09.2018
[2020/32]
Former [2020/31]HU26.09.2013
AL02.05.2018
CY02.05.2018
CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
MK02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
BG02.08.2018
MT26.09.2018
Former [2020/30]HU26.09.2013
AL02.05.2018
CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
BG02.08.2018
MT26.09.2018
Former [2020/08]AL02.05.2018
CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
BG02.08.2018
MT26.09.2018
Former [2019/51]AL02.05.2018
CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
BG02.08.2018
Former [2019/26]CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
BG02.08.2018
Former [2019/24]CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SK02.05.2018
SM02.05.2018
BG02.08.2018
Former [2019/11]CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SK02.05.2018
SM02.05.2018
BG02.08.2018
Former [2019/10]CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SK02.05.2018
BG02.08.2018
Former [2019/09]EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
RS02.05.2018
BG02.08.2018
Former [2018/51]HR02.05.2018
LT02.05.2018
LV02.05.2018
RS02.05.2018
BG02.08.2018
Former [2018/50]HR02.05.2018
LT02.05.2018
BG02.08.2018
Former [2018/47]LT02.05.2018
Cited inInternational search[A]WO2004000876  (PASTEUR INSTITUT [FR], et al) [A] 1-20 * figures 1-10 *;
 [A]WO2007105111  (PASTEUR INSTITUT [FR], et al) [A] 1-20 * sequences 7 - 12, 14, 16, 17, 21, 22, 24 - 29, 97, 99, 100, *;
 [A]CN102321639  (INST VIRAL DISEASE CONTROL & PREVENTION CHINESE CT DISEASE CONTROL & PREVENTION) [A] 1-20* abstract *;
 [A]  - WATARU AKAHATA ET AL, "A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection", vol. 16, no. 3, doi:10.1038/NM.2105, ISSN 1546-170X, (20100301), pages 334 - 338, NATURE MEDICINE, NATURE PUBLISHING GROUP, GB, URL: http://www.nature.com/nm/journal/v16/n3/pdf/nm.2105.pdf, (20100128), XP002676205 [A] 1-20 * page 334 - page 337; figures 1-4 *

DOI:   http://dx.doi.org/10.1038/NM.2105
 [A]  - KARTHIK MALLILANKARAMAN ET AL, "A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates", PLOS NEGLECTED TROPICAL DISEASES, (20110101), vol. 5, no. 1, doi:10.1371/journal.pntd.0000928, ISSN 1935-2727, pages e928 - e928, XP055005402 [A] 1-20 * page 1 - page 12; figures 1-7 *

DOI:   http://dx.doi.org/10.1371/journal.pntd.0000928
 [A]  - MUTHUMANI K ET AL, "Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus", VACCINE, ELSEVIER LTD, GB, vol. 26, no. 40, ISSN 0264-410X, (20080919), pages 5128 - 5134, (20080414), XP025349960 [A] 1-20 * page 5128 - page 5133; figures 1-6 *
 [A]  - WANG E ET AL, "Chimeric alphavirus vaccine candidates for chikungunya", VACCINE, ELSEVIER LTD, GB, vol. 26, no. 39, doi:10.1016/J.VACCINE.2008.07.054, ISSN 0264-410X, (20080915), pages 5030 - 5039, (20080808), XP024529232 [A] 1-20 * page 5031 - page 5038, column left; figures 1-7 *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2008.07.054
 [A]  - COMBREDET C ET AL, "A MOLECULARLY CLONES SCHWARZ STRAIN OF MEASLES VIRUS VACCINE INDUCES STRONG IMMUNE RESPONSES IN MACAQUES AND TRANSGENIC MICE", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20031101), vol. 77, no. 21, doi:10.1128/JVI.77.21.11546-11554.2003, ISSN 0022-538X, pages 11546 - 11554, XP009020048 [A] 1-20 * page 11547 - page 11548 * * page 1151 - page 11552; figures 4, 8 * * page 11552, column left, line 15, paragraph last *

DOI:   http://dx.doi.org/10.1128/JVI.77.21.11546-11554.2003
Examination   - BRANDLER SAMANTHA ET AL, "A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus", VACCINE, (20130604), vol. 31, no. 36, doi:10.1016/J.VACCINE.2013.05.086, ISSN 0264-410X, pages 3718 - 3725, XP028684509

DOI:   http://dx.doi.org/10.1016/j.vaccine.2013.05.086
    - AKAHATA WATARU ET AL, "A specific domain of the chikungunya virus e2 protein regulates particle formation in human cells: implications for alphavirus vaccine design", JOURNAL OF VIROLOGY (ONLINE), AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 86, no. 16, doi:10.1128/JVI.00370-12, ISSN 1098-5514, (20120801), pages 8879 - 8883, (20120530), XP009161988

DOI:   http://dx.doi.org/10.1128/JVI.00370-12
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.